


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
PAHC
Phibro Animal Health
$41.63
Strengths

Earnings are forecast to grow

Outperform the market
Chart
$41.68 (-0.12%)
$37.07 (+12.30%)
$28 (+48.68%)
$23.21 (+79.36%)
PAHC has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

PAHC overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
PAHC Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PAHC Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayWhat is PAHC current stock price?
What are PAHC stock strengths?
What is PAHC Risk Level?
What is PAHC market cap and volume?
What is PAHC current Stock IQ?
Should I buy PAHC stock right now?
Is PAHC a Strong Buy right now?
What does a 'Strong Buy' rating mean for PAHC?
What does a 'Strong Sell' rating mean for PAHC?
What factors influence PAHC's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-5.65%
+0.64%
+3.34%
+0.45%
PAHC
Phibro Animal Health
Current Price
$41.63
Stock Insights
Strengths

Earnings are forecast to grow

Outperform the market

Chart
$41.68 (-0.12%)
$37.07 (+12.30%)
$28 (+48.68%)
$23.21 (+79.36%)
PAHC Analysts Opinion
PAHC Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
PAHC Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
PAHC Street Sentiment is extremely bullish and have positive views on the near-term outlook
PAHC has Low risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

Average key support and resistance price levels.
PAHC Latest Analysis
Phibro (PAHC) Upgraded to Strong Buy: Heres What You Should Know. Phibro (PAHC) has been upgraded to a Zacks Rank #1 (Strong Buy) reflecting growing optimism about the companys earnings prospects. This might drive the stock higher in the near term.
Thu Nov 20, 2025
Wall Street Has a Positive Outlook on Phibro Animal Health Corporation (PAHC) Since Q1 2026 Results. Phibro Animal Health Corporation (NASDAQ:PAHC) is one of the Hottest Small Cap Stocks to Buy Now. On November 7 Ekaterina Knyazkova from J.P. Morgan raised the firms price target on Phibro Animal Health Corporation (NASDAQ:PAHC) from $45 to $50 and maintained a Buy rating. On the same day Erin Wright from Morgan Stanley also raised [….]
Mon Nov 17, 2025
Phibro Animal Health (PAHC) Price Target Increased by 31.63% to 43.86. The average one-year price target for Phibro Animal Health (NasdaqGM:PAHC) has been revised to $43.86 / share. This is an increase of 31.63% from the prior estimate of $33.32 dated November 7 2025. The price target is an average of many targets provided by an
Mon Nov 17, 2025
Why Phibro Animal Health (PAHC) is a Top Growth Stock for the Long-Term. Whether youre a value growth or momentum investor finding strong stocks becomes easier with the Zacks Style Scores a top feature of the Zacks Premium research service.
Thu Nov 13, 2025
Heres Why Phibro Animal Health (PAHC) is a Strong Value Stock. Wondering how to pick strong market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Mon Nov 10, 2025
Phibro Animal Health (PAHC) Q1 Earnings and Revenues Top Estimates. Phibro (PAHC) delivered earnings and revenue surprises of 23.73% and 2.60% respectively for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
Thu Nov 6, 2025
Phibro (PAHC) Reports Q1 Earnings: What Key Metrics Have to Say. Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended September 2025 it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Thu Nov 6, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
PAHC Stock trends
PAHC Stock performance
PAHC Stock analysis
PAHC investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.